Relationships between fibrinogen and insulin resistance

被引:59
作者
Raynaud, E [1 ]
Pérez-Martin, A
Brun, JF
Aïssa-Benhaddad, A
Fédou, C
Mercier, J
机构
[1] Fac Pharm Montpellier, Dept Metab & Clin Biochem, F-34060 Montpellier 2, France
[2] Lapeyronie Univ Hosp, CERAMM, F-34295 Montpellier, France
关键词
fibrinogen; insulin sensitivity; insulin; minimal model; metabolic syndrome;
D O I
10.1016/S0021-9150(99)00373-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A relationship between plasma fibrinogen levels and insulinemia, as well as the different parameters of the insulin resistance syndrome has been described. The aim of the present paper was to investigate whether plasma fibrinogen concentrations were linked to plasma insulin levels or to the degree of insulin resistance. For this purpose, 62 nondiabetic, nonhypertensive patients, 30 men and 32 women, with body mass indexes (BMIs) and ages ranging from 18.6 to 50.2 kg/m(2) and from 19 to 60 years, respectively, were studied. Insulin sensitivity was quantified by the minimal model procedure over a 180-min intravenous glucose tolerance test with iterative sampling. Plasma insulin was determined by radioimmunoassay without cross-reactivity to human proinsulin, and fibrinogen by the method of Clauss. Insulin sensitivity ranged from 0.009 to 23.2 min (- 1)(mu U/ml) x 10 (- 4), covering the whole range of insulin sensitivities. Fibrinogen ranged from 1.70 to 5.07 g/l. There was a significant negative correlation between fibrinogen and insulin sensitivity (r = - 0.76, P < 0.0001) and a positive correlation between fibrinogen and basal insulin (r = 0.56,P < 0.0001). After adjustment for BMI, body fat mass and waist-to-hip ratio, these two relationships remained significant. In addition, a multiple regression analysis was performed to assess the independent effect of the following related variables: fibrinogen, insulin sensitivity, insulinemia and BMI. Only insulin sensitivity appeared to account for the ability to predict fibrinogen values. Thus, we hypothesized it was likely that the state of insulin resistance rather than hyperinsulinemia per se was related to hyperfibrinogenemia. We proposed an interpretation of these data in connection with some factors like free fatty acids or tumor necrosis factor-alpha, which have been implicated in the pathogenesis of insulin resistance. Nevertheless, prospective and intervention studies are needed to assess whether there is a simple association or a causal relationship between insulin resistance and hyperfibrinogenemia. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:365 / 370
页数:6
相关论文
共 33 条
[1]  
ALESSI MC, 1988, THROMB HAEMOSTASIS, V60, P491
[2]   TOWARD PHYSIOLOGICAL UNDERSTANDING OF GLUCOSE-TOLERANCE - MINIMAL-MODEL APPROACH [J].
BERGMAN, RN .
DIABETES, 1989, 38 (12) :1512-1527
[3]   EQUIVALENCE OF THE INSULIN SENSITIVITY INDEX IN MAN DERIVED BY THE MINIMAL MODEL METHOD AND THE EUGLYCEMIC GLUCOSE CLAMP [J].
BERGMAN, RN ;
PRAGER, R ;
VOLUND, A ;
OLEFSKY, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :790-800
[4]   THE MAGNITUDE, THE KINETICS AND THE METABOLIC EFFICIENCY OF 1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE ARE RELATED [J].
BOUIX, O ;
BRUN, JF ;
ORSETTI, A .
HORMONE AND METABOLIC RESEARCH, 1993, 25 (06) :312-316
[5]   INFLUENCE OF SHORT-TERM SUBMAXIMAL EXERCISE ON PARAMETERS OF GLUCOSE ASSIMILATION ANALYZED WITH THE MINIMAL MODEL [J].
BRUN, JF ;
GUINTRANDHUGRET, R ;
BOEGNER, C ;
BOUIX, O ;
ORSETTI, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (07) :833-840
[6]  
BRUN JF, 1995, ENDOCRINOL METAB, V2, P203
[7]  
CONARD V, 1953, ARCH INT PHARMACOD T, V93, P277
[8]   FIBRINOGEN AND FIBRINOLYTIC VARIABLES IN RELATION TO ANTHROPOMETRY, LIPIDS AND BLOOD-PRESSURE - THE NORTHERN SWEDEN MONICA STUDY [J].
ELIASSON, M ;
EVRIN, PE ;
LUNDBLAD, D .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (05) :513-524
[9]   RELATIONSHIP OF CIGARETTE-SMOKING AND SNUFF DIPPING TO PLASMA-FIBRINOGEN, FIBRINOLYTIC VARIABLES AND SERUM-INSULIN - THE NORTHERN SWEDEN MONICA STUDY [J].
ELIASSON, M ;
ASPLUND, K ;
EVRIN, PE ;
LUNDBLAD, D .
ATHEROSCLEROSIS, 1995, 113 (01) :41-53
[10]   HEMOSTASIS VARIABLES IN TYPE-I DIABETIC-PATIENTS WITHOUT DEMONSTRABLE VASCULAR COMPLICATIONS [J].
ELKHAWAND, C ;
JAMART, J ;
DONCKIER, J ;
CHATELAIN, B ;
LAVENNE, E ;
MORIAU, M ;
BUYSSCHAERT, M .
DIABETES CARE, 1993, 16 (08) :1137-1145